aorta. Baseline measurements of MDV were obiamed on each beagle prior to 2 hours occlusion of the left anterior descending arlery (LAD) and then repeated at 4 hours reperfusion and also at day 4, 9, 16, 23 and 30 post. At day 30 post, the heart was removed following MDV measurement and scanned ex-viva at high spatial resolutmn before it was sliced and stained with TTC.
vs. 3.4%. P=O.14), while it was asswated with death at one year (12.2% vs. 7.2%. odds ratio = 1.78, 95% Cl 1.41 to 2.26, P < O.OOOl). There was increased risk of death with increasing Cornell voltage, especially in women. (Figure) Results: MDV in the apical region of the heart Increased from a mean baseline value of 0.4 f 0.1 ml/g to 0.9 * 0.05 ml/g immediately after reperfusion and remained above 0.6 ml/g until day 4 post. From day 9 post MDV normalized except for a thin subendocardial rim in the apical region. High resolution ex-viva scan of the removed heart confirmed the location of the rim enhancement seen in the MDV image to be subendocardial. TTC staining further confirmed that the rim enhancement was infarcted tissue. MDV in normal myocardium at the lateral free wall of the left ventricle was 0.4 * 0.05 mlJg at all time points.
Female

Conclusion:
We concluded from our preliminary results that ECG-gated contrastenhanced CT scanning is a promising and simple approach for studying myocardial damage from &hernia and its resolution with time.
9:45 a.m. Whereas electrocardiographic (ECG) left ventricular hypertrophy (LVH) predicts long-term mortality in otherwise healthy people, its importance as a predictor of death in the setting of NSTEMI acute coronary syndromes (ACS) is not known.
869-6
Methods:
Patients wth ACS who were enrolled in the GUSTO IV randomized trial had baseline ECGs read in a blinded core laboratory. LV mass was assessed by Cornell voltage, which is the sum of the amplitude of the S wave in V3 and the R wave in lead Vl.
LVH was defined as a voltage? 26 mm in men and 220 mm in women.
Results: Baseline ECG data were available in 7443 (95%) of 7800 patients enrolled.
ECG LVH was present in 747 patients (10%). During follow-up, 260 patients (3.5%) died by 30 days and 574 (7.7%) by 1 year. ECG LVH tended to predict death at 30 days (4.4% After adjusting for age, ST-segment depression, troponin, C reactive protein, and other confounders using logistic regression, Cornell voltage remained independently predictive of l-year mortality (p=O.OlE), but only in women (p&O31 for the interaction between
Cornell voltage and sex; I" gender specific analyses, p=O.O05 and 0.339 for Cornell voltage in women and men, respectively).
Conclusion:
EGG LVH at baseline is an independent predictor of lyear mortality among women presenting with ACS.
8:45 a.m.
872-2
The Background: ST segment elevation (STE) in lead aVR has been associated with severe coronary lesions in patients with acute coronary syndromes, but the prognostic significance of this finding is unknown.
Methods: We analyzed the initial EGG in 775 consecutive patients admitted to ~urcenter with a first acute myocardial infarction without STE in leads other than aVR.
Results: Compared to the remaining patients, those with STE in lead aVR had a higher baseline risk profile and a more frequent and extensive ST segment depression in other leads. The rates of death and other in-hospital complications were strongly associated with the magmtude of STE in lead aVR, while CK-MB levels were not (Table) . After adjustment for age, Killip class and presence and location of ST segment depression, the odds ratios for death in the last two groups shown in the table were, respectively, 5.6 (95% confidence interval, 2.0-15.5) and 7.6 (3.1-19.9). Among 437 patients catheterized within SIX months, those wth STE in lead aVR had a lower left ventricular ejection fraction and a more extensive coronary artery disease.
Conclusion:
Lead aVR contains important prognostic information in patients with a first acute myocardial infarction without other STE. As the wrse wtcome predicted by STE in lead aVR appears to be related to a more s?vera coronary artery disease, an early invasive approach might be especially beneficial in these patients. 
